| SC 13D/A | 2024-03-07 | Newtyn Management, LLC | Sensei Biotherapeutics, Inc. | 554,493 | 2.2% | EDGAR |
| SC 13D/A | 2024-02-13 | Newtyn Management, LLC | Sensei Biotherapeutics, Inc. | 768,921 | 3.1% | EDGAR |
| SC 13D | 2023-11-03 | Newtyn Management, LLC | Sensei Biotherapeutics, Inc. | 1,046,406 | 3.9% | EDGAR |
| SC 13G/A | 2023-08-04 | Cambrian BioPharma Inc | Sensei Biotherapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2023-06-02 | Apeiron Investment Group Ltd. | Sensei Biotherapeutics, Inc. | - | 0.0% | EDGAR |
| SC 13D/A | 2023-05-23 | Apeiron Investment Group Ltd. | Sensei Biotherapeutics, Inc. | 955,738 | 3.1% | EDGAR |
| SC 13D/A | 2023-03-09 | Apeiron Investment Group Ltd. | Sensei Biotherapeutics, Inc. | 955,738 | 3.1% | EDGAR |
| SC 13G/A | 2023-02-14 | Cambrian BioPharma Inc | Sensei Biotherapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2022-11-21 | Apeiron Investment Group Ltd. | Sensei Biotherapeutics, Inc. | 955,738 | 3.1% | EDGAR |
| SC 13D/A | 2022-11-02 | Apeiron Investment Group Ltd. | Sensei Biotherapeutics, Inc. | 955,738 | 3.1% | EDGAR |
| SC 13D | 2022-07-19 | Apeiron Investment Group Ltd. | Sensei Biotherapeutics, Inc. | 955,738 | 3.1% | EDGAR |
| SC 13G/A | 2022-06-10 | Cambrian BioPharma Inc | Sensei Biotherapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2022-02-14 | H&S INVESTMENTS I LP | Sensei Biotherapeutics, Inc. | 4,441,624 | 14.5% | EDGAR |
| SC 13G/A | 2022-02-10 | Apeiron Investment Group Ltd. | Sensei Biotherapeutics, Inc. | 955,738 | 3.1% | EDGAR |
| SC 13G | 2021-02-18 | Apeiron Investment Group Ltd. | Sensei Biotherapeutics, Inc. | 955,738 | 3.1% | EDGAR |
| SC 13G | 2021-02-16 | Peyer James | Sensei Biotherapeutics, Inc. | 0 | 0.0% | EDGAR |